Dealmaker Insights

Private Equity Spotlight: Cautious optimism – trends and challenges in health care private equity

Private Equity Spotlight: A conversation with Thomas Weinmann of REIA Capital

Private Equity Spotlight: Impact of corporate criminal liability changes

Private Equity Spotlight: Preparing for 2025’s antitrust landscape

Private Equity Spotlight: A conversation with Patrick Floeck of Valesco Industries

Private Equity Spotlight: The current state of the health care private equity market

FTC Non-Compete Ban: What you need to know

Private Equity Spotlight: A Conversation with Matt Carlos of New Water Capital

Private Equity Spotlight: New state notices and consent requirements in healthcare transactions

U.S. antitrust developments: FTC Section 5 and beyond (Part 3)

U.S. antitrust developments: Spotlight on new merger guidelines (Part 2)

Private Equity Spotlight: A conversation with Rush Harvey of Raymond James

U.S. antitrust developments: Antitrust enforcers take aim at private equity (Part 1)

Private Equity Spotlight: A conversation with Chris Baddon of Pacific Avenue Capital

Tips and tricks for startups before a financing

FDI in 2023: Three countries, three regimes

Talking tax: More questions than answers in crypto space

Roadmap to setting up business in the UAE

Seven tips to close the deal and leave competition issues behind

Guide to early-stage investment terms

IP diligence considerations for emerging growth companies

Protections for when contracts go wrong

Frustration and force majeure

A refresher on key contractual principles

Europe’s first CRE CLO: Lessons learned

Hedging risk-free rate transactions

CMBS: Destined to be on the naughty step forever?